Does SECUKINUMAB Cause Conjunctivitis? 237 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 237 reports of Conjunctivitis have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.2% of all adverse event reports for SECUKINUMAB.
237
Reports of Conjunctivitis with SECUKINUMAB
0.2%
of all SECUKINUMAB reports
11
Deaths
46
Hospitalizations
How Dangerous Is Conjunctivitis From SECUKINUMAB?
Of the 237 reports, 11 (4.6%) resulted in death, 46 (19.4%) required hospitalization, and 14 (5.9%) were considered life-threatening.
Is Conjunctivitis Listed in the Official Label?
Yes, Conjunctivitis is listed as a known adverse reaction in the official FDA drug label for SECUKINUMAB.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Conjunctivitis?
DUPILUMAB (5,270)
ADALIMUMAB (457)
METHOTREXATE (385)
ETANERCEPT (306)
PREDNISONE (250)
RITUXIMAB (222)
SULFAMETHOXAZOLE\TRIMETHOPRIM (218)
INFLIXIMAB (212)
LAMOTRIGINE (199)
TOCILIZUMAB (197)
Which SECUKINUMAB Alternatives Have Lower Conjunctivitis Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG